Type 1 diabetes is particularly a serious disease and its management has been a journey fraught with various challenges. But MIT engineering announces a revolution in the treatment of diabetes which can be potentially transformative. This innovation is an implantable device, containing not only insulin-producing cells but also its own oxygen production factory. It is incredible that this device is capable of producing oxygen by splitting the user’s vapor. This is a phenomenal feat, with its posi

MIT engineers have developed an implantable device for Type 1 diabetes treatment. The device contains insulin-producing cells and self-generates oxygen by splitting bodily water vapor. Promising results in diabetic mice show stabilized glucose levels. This advancement could eliminate daily insulin injections, offering a groundbreaking solution for diabetes management.